• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Conatus Pharmaceuticals Inc

+ Add to Watchlist

CNAT:US

6.3600 USD 0.1400 2.15%

As of 20:10:00 ET on 09/19/2014.

Company Profile for Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals, Inc. develops therapeutics to treat liver disease. The Company offers drugs to control programmed cell death that contributes to a range of liver diseases and cancer treatments. Conatus Pharmaceuticals provides its products in the United States.

Contact Information

Conatus Pharmaceuticals Inc

16745 West Bernardo Drive
Suite 200
San Diego, CA 92127
United States
Phone: 1-858-376-2600

Key Executives for Conatus Pharmaceuticals Inc (CNAT)

Steven J MentoPresident/CEO/Co-FounderCharles J CashionSenior VP:Finance/CFO/Secy
Gary Craig BurgessSenior VP:Clinical/Chief Medical OfcrAlfred P SpadaSenior VP:R&D/Chief Scientific Ofcr
Daniel L Ripley "Dan"Senior Dir/Head:Corporate Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil